Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.

Arch Gynecol Obstet · 2020 · PMC8494665 · PMID 32140806

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

a significant trendp < 0.0001actually significant

Also, a significant trend of risk reduction associated with increasing duration of use was reported ( p < 0.0001) in this study.

also in 9,775 other papers

borderline significantno p-value reported

[ 20 ] conducted a case-only study which resulted in a borderline significant association between genetic breast cancer and OC use compared with never use (OR = 1.3; 95% CI 1.0–1.7).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.